We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
(-46%)
Cap. Flow
-$438M
Cap. Flow
% of AUM
-78.37%
Top 10 Holdings %
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$25.1M |
| 2 |
Merck
MRK
|
+$9.57M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$9.37M |
| 4 |
BridgeBio Pharma
BBIO
|
+$9.02M |
| 5 |
Marvell Technology
MRVL
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
| 2 |
Citigroup
C
|
+$10.5M |
| 3 |
Microsoft
MSFT
|
+$9.87M |
| 4 |
OPTU
Optimum Communications Inc
OPTU
|
+$9.41M |
| 5 |
AES
AES
|
+$7.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.93% |
| 2 | Consumer Discretionary | 17.95% |
| 3 | Healthcare | 12.14% |
| 4 | Communication Services | 8.7% |
| 5 | Financials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
TSMC
TSM
$2.16T
| $10.5M | 1.88% |
87,293
-6,538
| -7% | -$766K |
|
|
CERN
2
DELISTED
Cerner Corp
CERN
| $10M | 1.8% |
107,994
+43,692
| +68% | +$3.32M |
|
|
MIME
3
DELISTED
Mimecast Limited
MIME
| $10M | 1.8% |
126,024
+80,595
| +177% | +$6.07M |
|
|
INFO
4
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $9.78M | 1.75% |
+73,573
| New | +$9.37M |
|
5
Alcoa
AA
$12.4B
| $9.43M | 1.69% |
158,238
+116,102
| +276% | +$5.82M |
|
|
6
Merck
MRK
$316B
| $9.21M | 1.65% |
+120,204
| New | +$9.57M |
|
7
Paychex
PAYX
$42.2B
| $8.74M | 1.56% |
64,024
+40,213
| +169% | +$4.97M |
|
|
8
Marvell Technology
MRVL
$196B
| $8.32M | 1.49% |
+95,148
| New | +$7.11M |
|
9
Wells Fargo
WFC
$267B
| $6.34M | 1.14% |
+132,176
| New | +$6.51M |
|
10
Medtronic
MDT
$110B
| $6.17M | 1.1% |
+59,628
| New | +$6.9M |
|
11
Tesla
TSLA
$1.29T
| $5.68M | 1.02% |
+16,128
| New | +$5.41M |
|
12
Meta Platforms (Facebook)
META
$1.5T
| $5.45M | 0.98% |
+16,203
| New | +$5.38M |
|
13
Coca-Cola
KO
$372B
| $5.26M | 0.94% |
+88,820
| New | +$4.95M |
|
14
Sea Limited
SE
$68.3B
| $5.15M | 0.92% |
+23,018
| New | +$6.87M |
|
15
Amazon
AMZN
$2.99T
| $4.98M | 0.89% |
+29,880
| New | +$5.11M |
|
16
Morgan Stanley
MS
$341B
| $4.92M | 0.88% |
50,169
+37,897
| +309% | +$3.78M |
|
17
Coupang
CPNG
$30.1B
| $4.73M | 0.85% |
161,107
-9,506
| -6% | -$268K |
|
18
Target
TGT
$67.3B
| $4.68M | 0.84% |
20,205
+5,195
| +35% | +$1.26M |
|
19
JPMorgan Chase
JPM
$950B
| $4.46M | 0.8% |
+28,167
| New | +$4.63M |
|
20
Delta Air Lines
DAL
$61B
| $4.42M | 0.79% |
113,141
+94,466
| +506% | +$3.78M |
|
21
Avantor
AVTR
$9.25B
| $4.34M | 0.78% |
102,907
+19,677
| +24% | +$776K |
|
22
FedEx
FDX
$74.1B
| $4.29M | 0.77% |
+16,570
| New | +$3.98M |
|
23
Palantir
PLTR
$390B
| $4.28M | 0.77% |
235,085
-61,717
| -21% | -$1.36M |
|
24
Restaurant Brands International
QSR
$25.6B
| $4.25M | 0.76% |
70,020
+44,519
| +175% | +$2.62M |
|
|
KEEL
25
Keel Infrastructure Corp
KEEL
$2.48B
| $4.24M | 0.76% |
839,987
+281,369
| +50% | +$1.74M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.
- Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
- Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
- Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
- Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
- Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
- Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
- Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.
Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.